Compare, Analyse AMAR REMEDIES with UNILEVER PLC. - UK - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs UNILEVER PLC. (UK) - Comparison Results

UNILEVER PLC. (UK)
   Change

Unilever is an Anglo–Dutch multinational consumer goods company. It is present in 11 categories broadly divided into home care, personal care, refreshments and foods. Personal care and foods are the large segments with sales shares of 35% and 28%, re... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   UNILEVER PLC.
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
UNILEVER PLC.
Dec-18
AMAR REMEDIES/
UNILEVER PLC.
5-Yr Chart
Click to enlarge
High Rs1644,761-   
Low Rs864,167-   
Sales per share (Unadj.) Rs261.62,455.0-  
Earnings per share (Unadj.) Rs17.4452.1-  
Cash flow per share (Unadj.) Rs22.3536.2-  
Dividends per share (Unadj.) Rs0125.98-  
Dividend yield (eoy) %02.8 0.0%  
Book value per share (Unadj.) Rs100.7591.9-  
Shares outstanding (eoy) m26.161,721.16-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.51.8 26.3%   
Avg P/E ratio x7.29.9 72.8%  
P/CF ratio (eoy) x5.68.3 67.4%  
Price / Book Value ratio x1.27.5 16.5%  
Dividend payout %027.9 0.0%   
Avg Mkt Cap Rs m3,2707,683,828 0.0%   
No. of employees `000NA155.0 0.0%   
Total wages/salary Rs m1630-   
Avg. sales/employee Rs ThNM27,260.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM5,020.4-  
INCOME DATA
Net Sales Rs m6,8444,225,388 0.2%  
Other income Rs m211,823 1.2%   
Total revenues Rs m6,8654,227,212 0.2%   
Gross profit Rs m1,1311,218,253 0.1%  
Depreciation Rs m128144,791 0.1%   
Interest Rs m39848,982 0.8%   
Profit before tax Rs m6261,026,303 0.1%   
Minority Interest Rs m0-34,727 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121213,416 0.1%   
Profit after tax Rs m455778,160 0.1%  
Gross profit margin %16.528.8 57.3%  
Effective tax rate %19.320.8 93.0%   
Net profit margin %6.618.4 36.1%  
BALANCE SHEET DATA
Current assets Rs m4,9041,283,065 0.4%   
Current liabilities Rs m3,5811,638,703 0.2%   
Net working cap to sales %19.3-8.4 -229.7%  
Current ratio x1.40.8 174.9%  
Inventory Days Days12431 403.5%  
Debtors Days Days10046 215.7%  
Net fixed assets Rs m1,689857,559 0.2%   
Share capital Rs m26238,456 0.7%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,6351,018,761 0.3%   
Long term debt Rs m5071,794,352 0.0%   
Total assets Rs m6,8624,927,713 0.1%  
Interest coverage x2.622.0 11.7%   
Debt to equity ratio x0.21.8 10.9%  
Sales to assets ratio x1.00.9 116.3%   
Return on assets %12.416.8 74.1%  
Return on equity %17.376.4 22.6%  
Return on capital %31.037.0 83.8%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-313559,689 -0.1%  
From Investments Rs m-489384,895 -0.1%  
From Financial Activity Rs m769-957,098 -0.1%  
Net Cashflow Rs m-33-6,548 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for UNILEVER PLC. (UK) is Euro. All data has been converted at 82.88 Rs / EUR

Compare AMAR REMEDIES With: P&G (US)  HYPERMARCAS (Brazil)  

Compare AMAR REMEDIES With: K.S.OILS LTD  BAJAJ CONSUMER CARE  PIDILITE INDUSTRIES  KARUTURI GLOBAL  RELAXO FOOTWEARS  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views On News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout... (The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMAR REMEDIES

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

OTHER USEFUL LINKS

MARKET STATS